Surgical and remote site infections after reconstructive surgery of the head and neck: A risk factor analysis.


Journal

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
ISSN: 1878-4119
Titre abrégé: J Craniomaxillofac Surg
Pays: Scotland
ID NLM: 8704309

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 02 02 2021
revised: 27 09 2021
accepted: 10 11 2021
pubmed: 23 11 2021
medline: 17 3 2022
entrez: 22 11 2021
Statut: ppublish

Résumé

The aim of this study was to identify risk factors for surgical (SSI) and remote site (RSI) infections, pathogens and antibiotic resistances in patients after pedicled and free flap reconstruction in the head and neck area. SSI criteria implicated infections affecting superficial or deep tissue in the flap area with purulent discharge, fistula, abscess formation and local infections signs. RSI criteria were defined as infections remote from the surgical site presenting with systemic symptoms like fever, leucocytosis, increase in C-reactive protein, purulent tracheobronchial secretion or deterioration of blood gases. Focus adequate specimen sampling and aerobic and anaerobic incubation and cultivation was performed. Epidemiological data, factors directly related to surgery or reconstruction, perioperative antibiotic regimen, length of stay, autologous blood transfusion and microbiological aspects were retrospectively analysed in 157 patients. 10.8% of patients presented SSI, 12.7% RSI. Cultivated bacteria were sampled from flap sites, blood cultures, central catheters and sputum including mainly gram-negative bacteria (70.3%) being frequently resistant against penicillin (85%) and third generation cephalosporine derivates (48%). Autologous blood transfusion (p = 0.018) and perioperative clindamycin use (p = 0.002) were independent risk factors for overall (SSI and RSI combined) infections. Prior radiation (p = 0.05), autologous blood transfusion (p = 0.034) and perioperative clindamycin use (p = 0.004) were predictors for SSIs. ASA >2 (p = 0.05) was a risk factor for remote site infections and prolonged ICU stay (p = 0.002) was associated with overall infections, especially in irradiated patients. Efforts need to be made in improving patient blood management, antibiotic stewardship and accurate postoperative care to avoid postoperative infections after head and neck reconstructive surgery.

Identifiants

pubmed: 34802884
pii: S1010-5182(21)00239-0
doi: 10.1016/j.jcms.2021.11.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

178-187

Informations de copyright

Copyright © 2021 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Johannes G Schuderer (JG)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany. Electronic address: johannes.schuderer@t-online.de.

Steffen Spörl (S)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Gerrit Spanier (G)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Maximilian Gottsauner (M)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

André Gessner (A)

Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.

Florian Hitzenbichler (F)

Department of Infection Prevention and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany.

Johannes K Meier (JK)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Torsten E Reichert (TE)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Tobias Ettl (T)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH